ImpriMed, Inc.
PrivateLast Round
Series A
Dec 19, 2023
Est. Valuation
$47.52M
Total Funding Raised
$27.03M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ImpriMed, Inc. is a precision medicine company that utilizes artificial intelligence and lab testing of live cancer cells to predict patient response to various cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImpriMed, Inc. Comparables
Compare ImpriMed, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FidoCure | 85% | |
| Anivive Lifesciences | 77% | |
| VetOmics | 74% | |
ImpriMed, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2023 | ||||
| VC Round | Apr 13, 2021 | ||||
| Seed | Apr 12, 2019 | ||||
| Pre Seed | Jun 1, 2018 |
Key People
Founding team and executive leadership
ImpriMed, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Draper Dragon | VC Round |
| StartX | Seed |
| Plug and Play Tech Center | Seed, Pre Seed |
| Han River Partners | Series A |
| Murex Partners | VC Round, Series A, Seed |
| BonAngels Venture Partners | VC Round |
| ES Investor | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Helped over 11,000 dogs and cats with cancer.
- Mar 4, 2026
Reached 288 specialty hospital customers in the US.
ImpriMed, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImpriMed, Inc.'s valuation, stock price, and market status.